NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase

OR Kolawole, K Kashfi - International journal of molecular sciences, 2022 - mdpi.com
Acute inflammation or resolved inflammation is an adaptive host defense mechanism and is
self-limiting, which returns the body to a state of homeostasis. However, unresolved …

A systematic review of glioblastoma-targeted therapies in phases II, III, IV clinical trials

E Cruz Da Silva, MC Mercier, N Etienne-Selloum… - Cancers, 2021 - mdpi.com
Simple Summary This review describes in a very detailed and exhaustive approach the
literature of these last 20 years on glioblastoma targeted therapies in Phases II-IV of 257 …

Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics

A Kirtonia, K Gala, SG Fernandes, G Pandya… - Seminars in cancer …, 2021 - Elsevier
Human malignancies are one of the major health-related issues though out the world and
anticipated to rise in the future. The development of novel drugs/agents requires a huge …

[HTML][HTML] WNT signaling in glioblastoma and therapeutic opportunities

Y Lee, JK Lee, SH Ahn, J Lee, DH Nam - Laboratory investigation, 2016 - Elsevier
WNTs and their downstream effectors regulate proliferation, death, and migration and cell
fate decision. Deregulation of WNT signaling is associated with various cancers including …

Glioblastoma cancer stem cell biology: Potential theranostic targets

F Sharifzad, S Ghavami, J Verdi, S Mardpour… - Drug Resistance …, 2019 - Elsevier
Glioblastoma multiforme (GBM) is among the most incurable cancers. GBMs survival rate
has not markedly improved, despite new radical surgery protocols, the introduction of new …

Wnt/β-catenin signaling pathway in the development and progression of colorectal cancer

K He, WJ Gan - Cancer Management and Research, 2023 - Taylor & Francis
The Wnt/β-catenin signaling pathway is a growth control pathway involved in various
biological processes as well as the development and progression of cancer. Colorectal …

Blocking the Wnt/β-catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies

Y Chen, M Chen, K Deng - International journal of …, 2022 - spandidos-publications.com
Colorectal cancer (CRC) is one of the most common malignant tumor types occurring in the
digestive system. The incidence of CRC has exhibits yearly increases and the mortality rate …

Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials

A Neiheisel, M Kaur, N Ma, P Havard… - … Journal of Cancer, 2022 - Wiley Online Library
Wnt signaling plays an essential role in the initiation and progression of various types of
cancer. Besides, the Wnt pathway components have been established as reliable …

The multifaced actions of curcumin in pregnancy outcome

G Tossetta, S Fantone, SR Giannubilo, D Marzioni - Antioxidants, 2021 - mdpi.com
Curcumin, also known as diferuloylmethane, is the main polyphenolic substance present in
the rhizomes of Curcuma longa L. This plant showed many beneficial effects and has been …

[HTML][HTML] Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

P Pantziarka, V Sukhatme, G Bouche… - …, 2016 - ncbi.nlm.nih.gov
Diclofenac (DCF) is a well-known and widely used non-steroidal anti-inflammatory drug
(NSAID), with a range of actions which are of interest in an oncological context. While there …